A Phase 2 Study of HB0017 in Psoriasis Patients | MicrobiomeTrials← Back to trialsNCT06592274
A Phase 2 Study of HB0017 in Psoriasis Patients
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2024-09-30Est. Completion: 2025-04-30
Enrollment target: 206 participants Locations- The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- Southern Medical University Dermatology Hospital, Guangzhou, Guangdong, China
- Xiangya Hospital of Central South University, Changsha, Hunan, China
- Wuxi Second People's Hospital, Wuxi, Jiangsu, China
- Jiangsu University Affiliated Hospital, Zhenjiang, Jiangsu, China
- Jilin University Second Hospital, Changchun, Jilin, China
- Shandong First Medical University Affiliated Dermatology Hospital, Jinan, Shandong, China
- Jining First People's Hospital, Jining, Shandong, China
- Xingtai People's Hospital, Xingtai, Shandong, China
- Shanxi Medical University Second Hospital, Taiyuan, Shanxi, China
- Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
- Chongqing Traditional Chinese Medicine Hospital, Chongqing, Sichuan, China
- Hangzhou First People's Hospital, Hangzhou, Zhejiang, China
- The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
- Jiaxing First Hospital, Jiaxing, Zhejiang, China
Other microbiome trials you might be interested in
Psoriasis (PsO)Psoriasis Arthritis
This study investigates changes in the skin and joints of people with psoriasis (PsO) and psoriatic arthritis (PsA) usin…
Multiple LocationsEst. completion Dec 31, 2027
Plaque Psoriasis
The main aim of this study is to assess whether secukinumab treatment retention over 12 months in adult patients with mo…
Multiple LocationsEst. completion Mar 31, 2027
Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang, ChinaGuangdong Provincial People's Hospital, Guangzhou, ChinaNingbo Second Hospital, Ningbo, China